Month: March 2021

Maryland’s diverse geography, economy, and English settlement in 1634 begat a rich music history. David K. Hildebrand will lead you through tracing musical evolution from the great tobacco plantations of the Chesapeake Bay, with their co-mingled African and British music, through the emergence and flourishing of Baltimore into a center of publishing, concerts, opera, church
0 Comments
What’s next for healthcare? It might be a broad question but events in the past several months have provided a clearer picture on where healthcare is headed. Let’s face it, the healthcare industry has changed partially because of the impact of COVID-19. Telehealth would definitely be on the list – but to be fair –
0 Comments
A team from the Universitat Politècnica de València (UPV) and the CIBER Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) has designed and tested, at a preclinical level, a new biomaterial for the treatment and recovery of muscle injuries. It is a boron-loaded alginate hydrogel, which would be administered with a subcutaneous injection. According to the tests carried
0 Comments
Researchers at Nanyang Technological University, Singapore (NTU Singapore) have developed an easy to perform CRISPR-based COVID-19 test that takes only 30 minutes for the results to come in. The test, which involves dipping a paper strip into a mixture containing a nasal sample, can identify various new variants of the virus, and could be useful
0 Comments
The user experience (UX) should be the starting point of designing any product, according to Dorothy Shamonsky, Ph.D., chief UX strategist at Integrated Computer Solutions Inc., in an interview with MD+DI.  “Although some product ideas are born because a new technology is developed, ideally the process then switches to focusing on the user experience,” she said.
0 Comments
Welcome to the MD+DI Book Club, a monthly feature where we recommend a book for medtech professionals. Title and Author: Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed, by John Sperzel, CEO of T2 Biosystems Rating: Currently rated 5 stars on Amazon, based on three ratings. Not yet rated on Goodreads. Recommended because: Part memoir, part call to
0 Comments
The world of flow cytometry is getting brighter as Beckman Coulter Life Sciences debuts its new SuperNova polymer dyes, featuring increased brightness and an improved staining index, which can enhance results in critical laboratory tests. Image Credit: Beckman Coulter Life Sciences – Flow Cytometry SuperNova dyes are a novel portfolio of polymer dyes that deliver
0 Comments
Predicting exactly what the future will look like is a fool’s errand. However, we can make educated predictions about the future, based on our understanding of how customer requirements and expectations are changing. We have established that COVID-19 has permanently altered customer requirements and expectations. The Big Three and the Oil Crisis of the 1970s
0 Comments
Large disease outbreaks have been associated with mental health problems. The current coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has negatively impacted millions of people worldwide, with many losing their jobs, businesses, and even loved ones. The spread of disease and increase in the death toll during a
0 Comments
FDA said Tuesday that it will allow the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent care settings, outpatient healthcare facilities and other patient care settings. The test, which uses female vaginal swabs and male urine specimens, is designed to detect the presence of the bacteria Chlamydia
0 Comments
Today, the U.S. Food and Drug Administration announced it is allowing the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent care settings, outpatient health care facilities and other patient care settings, operating under a CLIA Certificate of Waiver, Certificate of Compliance or Certificate of
0 Comments
Video highlights of COVID-19 data trends as of March 30, 2021. This daily report shares critical data on the spread of COVID-19 over the last 24 hours. For the latest news, trends, and expert insights on the coronavirus pandemic, visit the JHU Coronavirus Resource Center: https://coronavirus.jhu.edu/ Explore COVID-19 trends around the world with our in-depth
0 Comments
Scientists have reported that in most cases, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, mildly infects infants. However, around 10% of infants experienced severe COVID-19 infection who required advanced medical treatments. In rare cases, even asymptomatic infection can result in Multisystem Inflammatory Syndrome in
0 Comments